American Portfolios Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $35.9K | Sell |
423
-119
| -22% | -$10.1K | ﹤0.01% | 1897 |
|
|
2022
Q2 | $44.9K | Buy |
542
+11
| +2% | +$912 | ﹤0.01% | 1820 |
|
|
2022
Q1 | $40.9K | Buy |
531
+59
| +13% | +$4.55K | ﹤0.01% | 1981 |
|
|
2021
Q4 | $41.7K | Sell |
472
-60
| -11% | -$5.3K | ﹤0.01% | 1950 |
|
|
2021
Q3 | $41.1K | Buy |
532
+86
| +19% | +$6.65K | ﹤0.01% | 1881 |
|
|
2021
Q2 | $37.2K | Buy |
446
+31
| +7% | +$2.59K | ﹤0.01% | 1886 |
|
|
2021
Q1 | $31.3K | Hold |
415
| – | – | ﹤0.01% | 1824 |
|
|
2020
Q4 | $36.4K | Buy |
415
+72
| +21% | +$6.31K | ﹤0.01% | 1540 |
|
|
2020
Q3 | $26.1K | Buy |
343
+82
| +31% | +$6.24K | ﹤0.01% | 1581 |
|
|
2020
Q2 | $32.2K | Sell |
261
-6
| -2% | -$740 | ﹤0.01% | 1453 |
|
|
2020
Q1 | $22.6K | Buy |
267
+76
| +40% | +$6.42K | ﹤0.01% | 1485 |
|
|
2019
Q4 | $16.1K | Buy |
191
+34
| +22% | +$2.88K | ﹤0.01% | 1813 |
|
|
2019
Q3 | $10.6K | Buy |
157
+91
| +138% | +$6.13K | ﹤0.01% | 1911 |
|
|
2019
Q2 | $5.65K | Buy |
66
+21
| +47% | +$1.8K | ﹤0.01% | 2138 |
|
|
2019
Q1 | $4K | Hold |
45
| – | – | ﹤0.01% | 2169 |
|
|
2018
Q4 | $3.83K | Buy |
+45
| New | +$3.83K | ﹤0.01% | 1959 |
|